FLUDARABINE-TREOSULFAN REDUCED INTENSITY CONDITIONING REGIMEN PRIOR HAPLOIDENTICAL STEM CELL TRANSPLANTATION WITH POST TRANSPLANTATION CYCLOPHOSPHAMIDE FOR OLDER AND/OR FRAIL PATIENTS WITH AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Acute Myeloid Leukemia
Related studies linked through entity extraction aliases.
Efficacy and Safety of CD19-CAR.p40-T in Patients With Relapsed/Refractory CD19-Positive Hematologic Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
A Study to Assess Adverse Events and Change in Disease Activity When Intravenous (IV) Pivekimab Sunirine is Given in Combination With Oral Venetoclax and IV or Subcutaneous Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2/PHASE3
SHR2554/AZA + Overlapped Modified BUCY for High-risk/Relapsed Leukemia/MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
A Pragmatic Clinical Trial to Prevent Relapse for Myeloid Malignancies With Measurable Disease Prior to Allogeneic Transplant
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Salvage Haploidentical HSCT With DLI and Targeted Therapy for R/R AML
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Quantification of Peripheral Blood iNKTs After Allogeneic Stem Cell Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
Use of Electrical Bioimpedance in Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS) Patients (Bioimpedance)
- Status
- NOT_YET_RECRUITING
- Phase
- N/A
TBF Conditioning Regimen for Haploidentical Stem Cell Transplantation in Elderly AML Patients in First Complete Remission
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Bugitinib Combined With Venetoclax and Cytarabine in Relapsed/Refractory Acute Myeloid Leukemia
- Status
- RECRUITING
- Phase
- PHASE2
Menin-Inhibitor Targeted Maintenance in AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
SHR2554/AZA + Overlapped TBF for High-risk/Relapsed Leukemia/MDS
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
Study of the Effectiveness and Safety of Daunorubicin /Idarubicin ± Silibinin in Treating Newly Diagnosed AML (Non-M3).
- Status
- RECRUITING
- Phase
- PHASE4
Efficacy and Safety of Autologous Peptide-induced Active Immunity in AML Maintenance Therapy
- Status
- RECRUITING
- Phase
- PHASE1
Phase I Study Of PLM-102 In Patients With Relapsed And Refractory Acute Myeloid Leukemia
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Ruxolitinib With Azacitidine Maintenance for the Treatment of Patients With Acute Myeloid Leukemia Undergoing Reduced Intensity Allogeneic Stem Cell Transplantation
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Study of SA+X in the Treatment of Newly Diagnosed AML
- Status
- RECRUITING
- Phase
- PHASE2
Evaluation of Antibiotic Prophylaxis in Myelodysplastic Syndromes and Acute Myeloid Leukemia (MYELO-CAN:ABX)
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE2
my.naviGATE: A Guide to After-Treatment Effects for Adolescents and Young Adults
- Status
- NOT_YET_RECRUITING
- Phase
- NA
Axatilimab Combined With Decitabine/Venetoclax for the Treatment of TP53-mutated AML
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1